Valuation: Coloplast A/S

Capitalization 130B 20.18B 17.4B 16.15B 15.12B 28.05B 1,830B 30.23B 186B 73.46B 873B 75.65B 74.1B 3,184B P/E ratio 2026 *
22.5x
P/E ratio 2027 * 20.3x
Enterprise value 151B 23.41B 20.19B 18.73B 17.54B 32.53B 2,122B 35.06B 216B 85.21B 1,013B 87.75B 85.94B 3,693B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.79x
Free-Float
58.48%
Yield 2026 *
3.74%
Yield 2027 * 3.92%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.10%
1 week+2.01%
Current month+5.67%
1 month+5.17%
3 months-1.40%
6 months-4.69%
Current year+5.67%
More quotes
1 week 565
Extreme 565
584.2
1 month 535
Extreme 535
584.2
Current year 535
Extreme 535
584.2
1 year 535
Extreme 535
850.6
3 years 535
Extreme 535
993
5 years 535
Extreme 535
1,194
10 years 428
Extreme 428
1,194
More quotes
Manager TitleAgeSince
Chief Executive Officer 66 05/05/2025
Director of Finance/CFO 54 01/01/2006
Chief Operating Officer 59 05/09/2008
Director TitleAgeSince
Director/Board Member 78 13/12/2006
Director/Board Member 55 18/09/2009
Chairman 57 05/05/2025
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.10%+2.01%-28.54%-31.72% 20.2B
-2.17%+4.98%+61.82%+72.44% 3.86B
-1.99%+0.93%+24.37%-58.83% 3.14B
-4.54%-7.20%-9.53%-31.97% 3.04B
+2.49%+1.29%+231.76%+81.33% 2.69B
0.00%-5.30%-47.92%-29.38% 1.24B
+0.25%+2.43%+22.03%-3.91% 1.05B
0.00%+2.86%-11.76%+44.00% 1.03B
Average -0.73%+0.54%+30.28%+5.25% 4.53B
Weighted average by Cap. -0.54%+1.49%+7.85%-11.57%
See all sector performances

Financials

2026 *2027 *
Net sales 29.21B 4.53B 3.91B 3.63B 3.39B 6.3B 411B 6.79B 41.81B 16.49B 196B 16.98B 16.63B 715B 31.4B 4.87B 4.2B 3.9B 3.65B 6.77B 442B 7.3B 44.95B 17.73B 211B 18.26B 17.88B 768B
Net income 5.77B 895M 772M 716M 671M 1.24B 81.18B 1.34B 8.26B 3.26B 38.75B 3.36B 3.29B 141B 6.39B 991M 855M 793M 743M 1.38B 89.85B 1.48B 9.15B 3.61B 42.89B 3.72B 3.64B 156B
Net Debt 20.8B 3.23B 2.78B 2.58B 2.42B 4.48B 292B 4.83B 29.77B 11.74B 140B 12.09B 11.84B 509B 20.33B 3.15B 2.72B 2.52B 2.36B 4.38B 286B 4.72B 29.11B 11.48B 136B 11.82B 11.58B 498B
More financial data * Estimated data
Logo Coloplast A/S
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
16,744
More about the company
Date Price Change Volume
16/01/26 577.40 kr +0.10% 208,942
15/01/26 576.80 kr +0.70% 270,464
14/01/26 572.80 kr -0.62% 374,372
13/01/26 576.40 kr +0.45% 306,213
12/01/26 573.80 kr +1.38% 372,533

Delayed Quote Nasdaq Copenhagen, January 16, 2026 at 07:20 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
577.40DKK
Average target price
683.22DKK
Spread / Average Target
+18.33%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. COLO B Stock